The accuracy of risk scores in predicting ovarian malignancy: A systematic review

Obstetrics and Gynecology

Volumn 113, Issue 2 PART 1, 2009, Pages 384-394

  Geomini, Peggy ^a   Kruitwagen, Roy ^b   Bremer, Gérard L ^b   Cnossen, Jeltsje ^b   Mol, Ben W J ^b  

^a MÁXIMA MEDICAL CENTER   (Netherlands)

^b Maxima Medical Centre ^*

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; BIOLOGICAL MARKER;

ACCURACY; ADNEXA DISEASE; ARTICLE; CANCER RISK; DATA BASE; ECHOGRAPHY; HUMAN; MATHEMATICAL MODEL; MENOPAUSE; OVARY TUMOR; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUBLICATION; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; SYSTEMATIC REVIEW; ULTRASOUND; BIOLOGICAL MODEL; BLOOD; FEMALE; PATHOLOGY; PREDICTION AND FORECASTING; RISK FACTOR; ROC CURVE;

BIOLOGICAL MARKERS; FEMALE; HUMANS; MODELS, BIOLOGICAL; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE;

EID: 60549093608     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e318195ad17     Document Type: Article

References (98)

1. Winter WE 3rd, Maxwell GL, Tian C, Carlson JW, Ozols RF, Rose PG, et al. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol 2007;25:3621-7.
2. Trimbos JB, Vergote I, Bolis G, Vermorken JB, Mangioni C, Madronal C, et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 2003;95:113-25.
3. Medeiros LR, Fachel JM, Garry R, Stein AT, Furness S. Laparoscopy versus laparotomy for benign ovarian tumours. The Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD004751. DOI: 10.1002/14651858.CD004751. pub2.
4. Takac I. Receiver operating characteristic curves of transvag-inal Doppler blood flow measurements in benign and malignant adnexal tumors. J Ultrasound Med 1998;17:637-42.
5. Myers ER, Bastian LA, Havrilesky LJ, Kulasingam SL, Terplan MS, Cline KE, et al. Management of adnexal mass. Evid Rep Technol Assess (Full Rep) 2006;130:1-145.
6. Van Calster B, Timmerman D, Bourne T, Testa AC, Van Holsbeke C, Domali E, et al. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125. J Natl Cancer Inst 2007;99: 1706-14.
7. Alcázar JL, Jurado M. Using a logistic model to predict malignancy of adnexal masses based on menopausal status, ultrasound morphology, and color Doppler findings. Gynecol Oncol 1998;69:146-50.
8. DePriest PD, Shenson D, Fried A, Hunter JE, Andrews SJ, Gallion HH, et al. A morphology index based on sonographic findings in ovarian cancer. Gynecol Oncol 1993;51:7-11.
9. Ferrazzi E, Zanetta G, Dordoni D, Berlanda N, Mezzopane R, Lissoni AA. Transvaginal ultrasonographic characterization of ovarian masses: comparison of five scoring systems in a multicenter study. Ultrasound Obstet Gynecol 1997;10: 192-7.
10. Finkler NJ, Benacerraf B, Lavin PT, Wojciechowski C, Knapp RC. Comparison of serum CA 125, clinical impression, and ultrasound in the preoperative evaluation of ovarian masses. Obstet Gynecol 1988;72:659-64.
11. Granberg S, Norström A, Wikland M. Tumors in the lower pelvis as imaged by vaginal sonography. Gynecol Oncol 1990;37:224-9.
12. Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas JG. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol 1990;97:922-9.
13. Sassone AM, Timor-Tritsch IE, Artner A, Westhoff C, Warren WB. Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol 1991;78:70-6.
14. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, et al. Empirical evidence of designrelated bias in studies of diagnostic tests [published erratum appears in JAMA 2000;283:1963]. JAMA 1999;282:1061-6.
15. Van Houwelingen HC, Zwinderman KH, Stijnen T. A bivariate approach to meta-analysis. Stat Med 1993;12:2273-84.
16. Van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and metaregression. Stat Med 2002;21:589-624.
17. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 2005;58:982-90.
18. Arends LR, Hamza TH, Van Houwelingen JC, Heijenbrok-Kal MH, Hunink MG, Stijnen T. Bivariate random effects meta-analysis of ROC curves. Med Decis Making 2008;28: 621-38.
19. Mol BW, Boll D, De Kanter M, Heintz AP, Sijmons EA, Oei SG, et al. Distinguishing the benign and malignant adnexal mass: an external validation of prognostic models. Gynecol Oncol 2001;80:162-7.
20. Alcázar JL, Errasti T, Laparte C, Jurado M, Ló pez-García Assessment of a new logistic model in the preoperative evaluation of adnexal masses. J Ultrasound Med 2001;20: 841-8.
21. Alcázar JL, Ló pez-García G. Transvaginal color Doppler assessment of venous flow in adnexal masses. Ultrasound Obstet Gynecol 2001;17:434-8.
22. Alcázar JL, Mercé LT, Laparte C, Jurado M, Ló pez-García A new scoring system to differentiate benign from malignant adnexal masses. Am J Obstet Gynecol 2003;188:685-92.
23. Botta G, Zarcone R. Trans-vaginal ultrasound examination of ovarian masses in premenopausal women. Eur J Obstet Gynecol Reprod Biol 1995;62:37-41.
24. Buckshee K, Temsu I, Bhatla N, Deka D. Pelvic examination, transvaginal ultrasound and transvaginal color Doppler sonography as predictors of ovarian cancer. Int J Gynaecol Obstet 1998;61:51-7.
25. Caruso A, Caforio L, Testa AC, Ciampelli M, Panici PB, Mancuso S. Transvaginal color Doppler ultrasonography in the presurgical characterization of adnexal masses. Gynecol Oncol 1996;63:184-91.
26. Durdević S. Diagnostic importance of the sonographic scoring system in differentiating between malignant and benign ovarian tumors [in Croatian]. Med Pregl 2001;54:161-5.
27. Gramellini D, Rutolo S, Verrotti C, Piantelli G, Fieni S, Vadora E. Sonographic characterization, Doppler ultrasonography and tumor markers in the diagnosis of malignancy of ovarian masses [in Italian]. Minerva Ginecol 2001;53:1-11.
28. Leeners B, Schild RL, Funk A, Hauptmann S, Kemp B, Schröder W, et al. Colour Doppler sonography improves the pre-operative diagnosis of ovarian tumours made using conventional transvaginal sonography. Eur J Obstet Gynecol Reprod Biol 1996;64:79-85.
29. Schneider VL, Schneider A, Reed KL, Hatch KD. Comparison of Doppler with two-dimensional sonography and CA 125 for prediction of malignancy of pelvic masses. Obstet Gynecol 1993;81:983-8.
30. Sengoku K, Satoh T, Saitoh S, Abe M, Ishikawa M. Evaluation of transvaginal color Doppler sonography, transvaginal sonography and CA 125 for prediction of ovarian malignancy. Int J Gynaecol Obstet 1994;46:39-43.
31. Szpurek D, Moszynski R, Zietkowiak W, Spaczynski M, Sajdak S. An ultrasonographic morphological index for prediction of ovarian tumor malignancy. Eur J Gynaecol Oncol 2005;26:51-4.
32. Timor-Tritsch LE, Lerner JP, Monteagudo A, Santos R. Transvaginal ultrasonographic characterization of ovarian masses by means of color flow-directed Doppler measurements and a morphologic scoring system. Am J Obstet Gynecol 1993;168:909-13.
33. Topuz S, Saygili H, Akhan S, Yavuz E, Turfanda A, Berkman S. Differentiation of benign and malignant adnexal masses: value of a morphologic scoring system. Eur J Gynaecol Oncol 2005;26:209-12.
34. Wanapirak C, Nimitwongsakul S, Tongsong T. Sonographic morphology scores (SMS) for differentiation between benign and malignant ovarian tumor. J Med Assoc Thai 2001;84: 30-5.
35. Tempe A, Singh S, Wadhwa L, Garg A. Conventional and color Doppler sonography in preoperative assessment of ovarian tumors. Int J Gynaecol Obstet 2006;92:64-8.
36. Jurado M. Prospective evaluation of a logistic model based on sonographic morphologic and color Doppler findings developed to predict adnexal malignancy. J Ultrasound Med 1999;18:837-42.
37. Aslam N, Banerjee S, Carr JV, Savvas M, Hooper R, Jurkovic D. Prospective evaluation of logistic regression models for the diagnosis of ovarian cancer. Obstet Gynecol 2000;96:75-80.
38. Marret H, Ecochard R, Giraudeau B, Golfier F, Raudrant D, Lansac J. Color Doppler energy prediction of malignancy in adnexal masses using logistic regression models. Ultrasound Obstet Gynecol 2002;20:597-604.
39. Lerner JP, Timor-Tritsch IE, Federman A, Abramovich G. Transvaginal ultrasonographic characterization of ovarian masses with an improved, weighted scoring system. Am J Obstet Gynecol 1994;170:81-5.
40. Clayton RD, Snowden S, Weston MJ, Mogensen O, Eastaugh J, Lane G. Neural networks in the diagnosis of malignant ovarian tumours. Br J Obstet Gynaecol 1999;106:1078-82.
41. Predanic M, Vlahos N, Pennisi JA, Moukhtar M, Aleem FA. Color and pulsed Doppler sonography, gray-scale imaging, and serum CA 125 in the assessment of adnexal disease. Obstet Gynecol 1996;88:283-8.
42. Valentin L. Prospective cross-validation of Doppler ultrasound examination and gray-scale ultrasound imaging for discrimination of benign and malignant pelvic masses. Ultrasound Obstet Gynecol 1999;14:273-83.
43. Valentin L. Comparison of Lerner score, Doppler ultrasound examination, and their combination for discrimination between benign and malignant adnexal masses. Ultrasound Obstet Gynecol 2000;15:143-7.
44. DePriest PD, Varner E, Powell J, Fried A, Puls L, Higgins R, et al. The efficacy of a sonographic morphology index in identifying ovarian cancer: a multi-institutional investigation. Gynecol Oncol 1994;55:174-8.
45. Itakura T, Kikkawa F, Kajiyama H, Mitsui T, Kawai M, Mizutani S. Doppler flow and arterial location in ovarian tumors. Int J Gynaecol Obstet 2003;83:277-83.
46. Berlanda N, Ferrari MM, Mezzopane R, Boero V, Grijuela B, Ferrazzi E, et al. Impact of a multiparameter, ultrasoundbased triage on surgical management of adnexal masses. Ultrasound Obstet Gynecol 2002;20:181-5.
47. Daponte A, Stergioti E, Messinis IE. Risk scoring for adnexal masses and endoscopic management. Int J Gynaecol Obstet 2007;96:42-3.
48. Ferrazzi E, Lissoni AA, Dordoni D, Trio D, Redaelli L, Rusconi C, et al. Differentiation of small adnexal masses based on morphologic characteristics of transvaginal sonoraphic imaging: a multicenter study. J Ultrasound Med 2005;24:1467-73.
49. Romagnolo C, Trivella G, Bonacina M, Fornalè M, Maggino T, Ferrazzi E. Preoperative diagnosis of 221 consecutive ovarian masses: scoring system and expert evaluation. Eur J Gynaecol Oncol 2006;27:487-9.
50. Bromley B, Goodman H, Benacerraf BR. Comparison between sonographic morphology and Doppler waveform for the diagnosis of ovarian malignancy. Obstet Gynecol 1994; 83:434-7
51. Benacerraf BR, Finkler NJ, Wojciechowski C, Knapp RC. Sonographic accuracy in the diagnosis of ovarian masses. J Reprod Med 1990;35:491-5.
52. Aslam N, Tailor A, Lawton F, Carr J, Savvas M, Jurkovic D. Prospective evaluation of three different models for the pre-operative diagnosis of ovarian cancer. BJOG 2000;107: 1347-53.
53. Manjunath AP, Pratapkumar Sujatha K, Vani R. Comparison of three risk of malignancy indices in evaluation of pelvic masses. Gynecol Oncol 2001;81:225-9.
54. Tingulstad S, Hagen B, Skjeldestad FE, Onsrud M, Kiserud T, Halvorsen T, et al. Evaluation of a risk of malignancy index based on serum CA 125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses. Br J Obstet Gynaecol 1996;103:826-31.
55. Van Holsbeke C, Van Calster B, Valentin L, Testa AC, Ferrazzi E, Dimou I, et al. External validation of mathematical models to distinguish between benign and malignant adnexal tumors: a multicenter study by the International Ovarian Tumor Analysis Group. Clin Cancer Res 2007;13: 4440-7.
56. Asif N, Sattar A, Dawood MM, Rafi T, Aamir M, Anwar M. Pre-operative evaluation of ovarian mass: risk of malignancy index. J Coll Physicians Surg Pak 2004;14:128-31.
57. Obeidat BR, Amarin ZO, Latimer JA, Crawford RA. Risk of malignancy index in the preoperative evaluation of pelvic masses. Int J Gynaecol Obstet 2004;85:255-8.
58. Morgante G, la Marca A, Ditto A, De Leo, V. Comparison of two malignancy risk indices based on serum CA 125, ultrasound score and menopausal status in the diagnosis of ovarian masses. Br J Obstet Gynaecol 1999;106:524-7.
59. Timmerman D, Verrelst H, Bourne TH, De Moor B, Collins WP, Vergote I, et al. Artificial neural network models for the preoperative discrimination between malignant and benign adnexal masses. Ultrasound Obstet Gynecol 1999;13:17-25.
60. Hagen B, Tingulstad S, Onsrud M, Moen M, Kiserud T, Eik-Nes S, et al. Preoperative identification of malignancy among women with a pelvic mass. Evaluation of a risk index based on ultrasound findings. CA 125 in serum and meno-pausal status [in Norwegian]. Tidsskr Nor Laegeforen 1995; 115:820-2.
61. Davies AP, Jacobs I, Woolas R, Fish A, Oram D. The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index. Br J Obstet Gynaecol 1993;100:927-31.
62. Ulusoy S, Akbayir O, Numanoglu C, Ulusoy N, Odabas E, Gulkilik A. The risk of malignancy index in discrimination of adnexal masses. Int J Gynaecol Obstet 2007;96:186-91.
63. Yazbek J, Aslam N, Tailor A, Hillaby K, Raju KS, Jurkovic D. A comparative study of the risk of malignancy index and the ovarian crescent sign for the diagnosis of invasive ovarian cancer. Ultrasound Obstet Gynecol 2006;28:320-4.
64. Van Calster B, Timmerman D, Lu C, Suykens JA, Valentin L, Van Holsbeke C, et al. Preoperative diagnosis of ovarian tumors using Bayesian kernel-based methods. Ultrasound Obstet Gynecol 2007;29:496-504.
65. Andersen ES, Knudsen A, Rix P, Johansen B. Risk of malignancy index in the preoperative evaluation of patients with adnexal masses. Gynecol Oncol 2003;90:109-12.
66. Ma S, Shen K, Lang J. A risk of malignancy index in preoperative diagnosis of ovarian cancer. Chin Med J (Engl) 2003;116:396-9.
67. Tingulstad S, Hagen B, Skjeldestad FE, Halvorsen T, Nustad K, Onsrud M. The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals. Obstet Gynecol 1999;93:448-52.
68. Torres JC, Derchain SF, Faundes A, Gontijo RC, Martinez EZ, Andrade LA. Risk-of-malignancy index in preoperative evaluation of clinically restricted ovarian cancer. Sao Paulo Med J 2002;120:72-6.
69. Tailor A, Jurkovic D, Bourne TH, Collins WP, Campbell S. Sonographic prediction of malignancy in adnexal masses using multivariate logistic regression analysis. Ultrasound Obstet Gynecol 1997;10:41-7.
70. Valentin L, Hagen B, Tingulstad S, Eik-Nes S. Comparison of 'pattern recognition' and logistic regression models for discrimination between benign and malignant pelvic masses: a prospective cross validation. Ultrasound Obstet Gynecol 2001;18:357-65.
71. Timmerman D, Testa AC, Bourne T, Ferrazzi E, Ameye L, Konstantinovic ML, et al. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group. J Clin Oncol 2005;23:8794-801.
72. Brown DL, Doubilet PM, Miller FH, Frates MC, Laing FC, DiSalvo DN, et al. Benign and malignant ovarian masses: selection of the most discriminating gray-scale and Doppler sonographic features. Radiology 1998;208:103-10.
73. Kishi N. Preoperative discrimination between benign and malignant ovarian tumors by multivariate analysis [in Japanese]. Nippon Gan Chiryo Gakkai Shi 1990 20;25:2702-10.
74. Kobal B, Rakar S, Ribic-Pucelj M, Tomazevic T, Zaletel-Kragelj L. Pretreatment evaluation of adnexal tumors predicting ovarian cancer. Int J Gynecol Cancer 1999;9:481-6.
75. Minaretzis D, Tsionou C, Tziortziotis D, Michalas S, Aravantinos D. Ovarian tumors: prediction of the probability of malignancy by using patient's age and tumor morphologic features with a logistic model. Gynecol Obstet Invest 1994; 38:140-4.
76. Prömpeler HJ, Madjar H, Sauerbrei W, Lattermann U, Pfleiderer A. Diagnostic formula for the differentiation of adnexal tumors by transvaginal sonography. Obstet Gynecol 1997;89: 428-33.
77. Schelling M, Braun M, Kuhn W, Bogner G, Gruber R, Gnirs J, et al. Combined transvaginal B-mode and color Doppler sonography for differential diagnosis of ovarian tumors: results of a multivariate logistic regression analysis. Gynecol Oncol 2000; 77:78-86.
78. Smoleń A, Czekierdowski A, Daniłoś J, Kraczkowski J. Sonoangiography and logistic regression analysis in the preoperative differentiation of ovarian tumors [in Polish]. Ginekol Pol 2002;73:1053-60.
79. Szpurek D, Moszynski R, Smolen A, Sajdak S. Using logistic regression analysis in preliminary differential diagnosis of adnexal masses [published erratum appears in Int J Gynecol Cancer 2005;15:1260]. Int J Gynecol Cancer 2005;15: 817-23.
80. Timmerman D, Bourne TH, Tailor A, Collins WP, Verrelst H, Vandenberghe K, et al. A comparison of methods for preoperative discrimination between malignant and benign adnexal masses: the development of a new logistic regression model. Am J Obstet Gynecol 1999;181:57-65.
81. Yamashita Y, Hatanaka Y, Torashima M, Takahashi M, Miyazaki K, Okamura H. Characterization of sonographically indeterminate ovarian tumors with MR imaging. A logistic regression analysis. Acta Radiol 1997;38:572-7.
82. Balbi GC, Musone R, Menditto A, Balbi F, Corcioni C, Calabria G, et al. Women with a pelvic mass: indicators of malignancy. Eur J Gynaecol Oncol 2001;22:459-62.
83. Jokubkiene L, Sladkevicius P, Valentin L. Does three-dimensional power Doppler ultrasound help in discrimination between benign and malignant ovarian masses? Ultrasound Obstet Gynecol 2007;29:215-25.
84. Moore RG, Brown AK, Miller MC, Skates S, Allard WJ, Verch T, et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecol Oncol 2008;108:402-8.
85. Moszynski R, Szpurek D, Smolen A, Sajdak S. Comparison of diagnostic usefulness of predictive models in preliminary differentiation of adnexal masses. Int J Gynecol Cancer 2006;16:45-51.
86. Mousavi AS, Borna S, Moeinoddini S. Estimation of probability of malignancy using a logistic model combining color Doppler ultrasonography, serum CA 125 level in women with a pelvic mass. Int J Gynecol Cancer 2006;16 Suppl 1:92-8.
87. Smoleń A, Szpurek D, Czekierdowski A, Moszyń ski R. Characteristics of ovarian tumors with color Doppler sonography: a comparison of predictive models derived from two academic centers data [in Polish]. Ginekol Pol 2003;74: 863-71.
88. Valentin L, Ameye L, Jurkovic D, Metzger U, Lécuru F, Van Huffel S, et al. Which extrauterine pelvic masses are difficult to correctly classify as benign or malignant on the basis of ultrasound findings and is there a way of making a correct diagnosis? Ultrasound Obstet Gynecol 2006;27:438-44.
89. Lu C, Suykens JAK, Timmerman D, Vergote I, Van Huffel S, et al. Linear and nonlinear preoperative classification of ovarian tumors. In: Ichimura T, Yoshida K, editors. Knowledge based intelligent systems for health care. International Series on Advanced Intelligence 7. Magill, Adelaide (AU); Advanced Knowledge International; 2004. p. 343-382.
90. Szpurek D, Moszynski R, Smolen A, Sajdak S. Artificial neural network computer prediction of ovarian malignancy in women with adnexal masses. Int J Gynaecol Obstet 2005;89: 108-13.
91. Tailor A, Jurkovic D, Bourne TH, Collins WP, Campbell S. Sonographic prediction of malignancy in adnexal masses using an artificial neural network. Br J Obstet Gynaecol 1999;106:21-30.
92. Zhang Z, Barnhill SD, Zhang H, Xu F, Yu Y, Jacobs I, et al. Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses. Gynecol Oncol 1999;73: 56-61.
93. Zhang Z, Yu Y, Xu F, Berchuck A, van Haaften-Day C, Havrilesky LJ, et al. Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer. Gynecol Oncol 2007;107:526-31.
94. Lu C, Van Gestel T, Suykens JA, Van Huffel S, Vergote I, Timmerman D. Preoperative prediction of malignancy of ovarian tumors using least squares support vector machines. Artif Intell Med 2003;28:281-306.
95. Vernooij F, Heintz P, Witteveen E, van der Graaf Y. The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review. Gynecol Oncol 2007;105:801-12.
96. The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer. Gynecol Oncol 2002;87: 237-9.
97. Dearking AC, Aletti GD, McGree ME, Weaver AL, Sommer-field MK, Cliby WA. How relevant are ACOG and SGO guidelines for referral of adnexal mass? Obstet Gynecol 2007;110:841-8.
98. Bailey J, Tailor A, Naik R, Lopes A, Godfrey K, Hatem HM, et al. Risk of malignancy index for referral of ovarian cancer cases to a tertiary center: does it identify the correct cases? Int J Gynecol Cancer 2006;16 Suppl 1:30-4.